NEKTAR THERAPEUTICS Quarterly Other Assets, Current in USD from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
Nektar Therapeutics quarterly Other Assets, Current history and growth rate from Q4 2010 to Q2 2024.
  • Nektar Therapeutics Other Assets, Current for the quarter ending June 30, 2024 was $8.29M, a 13.6% decline year-over-year.
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $8.29M -$1.31M -13.6% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $10.7M -$266K -2.42% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $9.78M -$6.03M -38.1% Dec 31, 2023 10-Q 2024-08-09
Q3 2023 $9.03M -$13.5M -59.9% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $9.6M -$9.64M -50.1% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $11M -$9.82M -47.2% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $15.8M -$7.53M -32.3% Dec 31, 2022 10-K 2024-03-05
Q3 2022 $22.5M +$1.78M +8.57% Sep 30, 2022 10-Q 2022-11-04
Q2 2022 $19.2M +$6.65M +52.8% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $20.8M +$5.06M +32.1% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $23.3M +$1.41M +6.41% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $20.7M -$819K -3.8% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 $12.6M -$25.2M -66.7% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 $15.8M +$1.96M +14.2% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 $21.9M +$6.54M +42.5% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $21.6M +$6.34M +41.7% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $37.8M +$24.6M +186% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 $13.8M -$5.54M -28.6% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 $15.4M -$5.91M -27.7% Dec 31, 2019 10-K 2021-02-26
Q3 2019 $15.2M +$2.67M +21.3% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $13.2M -$21.7M -62.2% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $19.4M +$6.28M +48% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $21.3M +$13.5M +173% Dec 31, 2018 10-K 2020-02-28
Q3 2018 $12.5M -$720K -5.43% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 $34.9M +$27.4M +366% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 $13.1M +$5.19M +65.9% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 $7.79M -$2.27M -22.6% Dec 31, 2017 10-K 2019-03-01
Q3 2017 $13.3M +$9.25M +231% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 $7.5M +$2.07M +38.1% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 $7.88M +$2.29M +40.9% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 $10.1M +$249K +2.54% Dec 31, 2016 10-K 2018-03-01
Q3 2016 $4.01M -$1.21M -23.1% Sep 30, 2016 10-Q 2016-11-04
Q2 2016 $5.43M -$3.36M -38.2% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 $5.59M -$499K -8.19% Mar 31, 2016 10-Q 2016-05-04
Q4 2015 $9.81M +$997K +11.3% Dec 31, 2015 10-K 2017-03-01
Q3 2015 $5.21M +$506K +10.7% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 $8.78M +$4.15M +89.7% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 $6.09M +$120K +2.01% Mar 31, 2015 10-Q 2015-05-01
Q4 2014 $8.82M +$3.64M +70.4% Dec 31, 2014 10-K 2016-03-01
Q3 2014 $4.71M -$51K -1.07% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 $4.63M -$1.39M -23.1% Jun 30, 2014 10-Q 2014-08-01
Q1 2014 $5.97M -$2.84M -32.2% Mar 31, 2014 10-Q 2014-05-08
Q4 2013 $5.18M -$8.19M -61.3% Dec 31, 2013 10-K 2015-02-26
Q3 2013 $4.76M -$2.24M -32% Sep 30, 2013 10-Q 2013-11-07
Q2 2013 $6.02M -$3.32M -35.6% Jun 30, 2013 10-Q 2013-08-09
Q1 2013 $8.81M -$4.82M -35.4% Mar 31, 2013 10-Q 2013-05-09
Q4 2012 $13.4M -$4.58M -25.5% Dec 31, 2012 10-K 2014-02-27
Q3 2012 $7M -$562K -7.43% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 $9.34M +$1.41M +17.8% Jun 30, 2012 10-Q 2012-08-09
Q1 2012 $13.6M +$6.78M +98.8% Mar 31, 2012 10-Q 2012-05-04
Q4 2011 $17.9M +$12.3M +216% Dec 31, 2011 10-K 2013-03-01
Q3 2011 $7.57M Sep 30, 2011 10-Q 2011-11-04
Q2 2011 $7.93M Jun 30, 2011 10-Q 2011-08-05
Q1 2011 $6.86M Mar 31, 2011 10-Q 2011-04-29
Q4 2010 $5.68M Dec 31, 2010 10-K 2012-02-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.